DR info

Clinical trials : 4 / Drugs : 7 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 51

Drugs and their primary sponsors and trial info

Prodarsan
   DNage B.V.
      2010   Phase 1/Phase 2   NCT01142154   United States;
Quercetin
   The First Medical Center of PLA General Hospital
      2019   Phase 0   ChiCTR1900026719   China;
Sirolimus
   Premier Specialists, Australia
      2016   Phase 2   NCT03016715   Australia;
Sirolimus,
   Stanford University
      2016   Phase 2   NCT02960997   United States;
Vehicle
   Premier Specialists, Australia
      2016   Phase 2   NCT03016715   Australia;
   Stanford University
      2016   Phase 2   NCT02960997   United States;
Vitamin C
   The First Medical Center of PLA General Hospital
      2019   Phase 0   ChiCTR1900026719   China;